Biote (BTMD) EBIAT (2021 - 2026)

Biote has reported EBIAT for 6 years, with the latest figure at $2.7 million in Q1 2026.

• For the quarter ending Q1 2026, EBIAT fell 83.1% year-over-year to $2.7 million; the trailing twelve-month figure through Mar 2026 stood at $22.3 million (up 13.57% YoY), and the FY2025 full-year result was $31.6 million, up 68589.13% from the prior year.
• EBIAT for Q1 2026 stood at $2.7 million, down from $6.5 million in the prior quarter.
• The five-year high for EBIAT was $18.2 million in Q4 2023, with the low at -$21.4 million in Q1 2023.
• Average EBIAT over 5 years is $463588.2, with a median of $3.5 million recorded in 2024.
• Peak annual rise in EBIAT reached 50100.0% in 2023, while the deepest fall reached 329.2% in 2023.
• Tracing BTMD's EBIAT over 5 years: stood at -$7.8 million in 2022, then soared by 332.75% to $18.2 million in 2023, then sank by 80.86% to $3.5 million in 2024, then soared by 86.79% to $6.5 million in 2025, then sank by 58.87% to $2.7 million in 2026.
• The last three EBIAT figures came in at $2.7 million (Q1 2026), $6.5 million (Q4 2025), and $9.2 million (Q3 2025), per Business Quant data.

Peer Comparison